Acceptability of the NuvaRing Among Students

Completed · Phase 4

Conditions studied: Birth Control Compliance

In brief

The ACCEPT study is a Phase IV trial in which women are randomized to either the NuvaRing® vaginal contraceptive ring or a low dose oral contraceptive to assess compliance, side effects, overall acceptability and intent to continue use of the method. The study is focused on the acceptability of the vaginal ring among female undergraduate or graduate students.

Key facts

Study ID

NCT00635570

Run by

University of Chicago

People needed

273

Starts

2008-07-01

Expected to finish

2009-07-01

Last updated by the study team

2021-02-03

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• over 18
• student enrolled in college or graduate program
• Not have used the contraceptive patch or oral contraceptives within the last month
• Never have used a contraceptive vaginal ring
• Interested in using hormonal contraceptives, specifically NuvaRing and oral contraceptive pills for next 3 months
• In general good health
• Premenopausal with the ability to menstruate

You may not qualify if…

• Known or suspected pregnancy
• Pregnancy within 2 months of trial medication
• Past use of any contraceptive vaginal ring
• Hypersensitivity or allergy to NuvaRing or Oral Contraceptives
• Use of investigational drug within 2 months of start of trial medication
• Use of the contraceptive patch or oral contraceptives within past month
• Use of any injectable contraception within 6 months of trial medication
• Planning pregnancy in next 6 months

Where it is running

• University of Chicago, Section of Family Planning — Chicago, Illinois, United States
• University of Chicago — Chicago, Illinois, United States
• University of Illinois — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.